Start Portfolio Strategy (SPOCK) Program

​​​​​​​

Are you a future oriented, digitally savvy leader, passionate about strategy and decision making? As a member of the Start Portfolio Strategy (SPOCK) program in Pharma Research and Early Development (pRED), you will have the opportunity to demonstrate your abilities and potential through a two year rotation program. Throughout the program you will have a senior pRED leader that will mentor you and support your progress.

About the program


RECRUITMENT
Stay tuned for future hiring rounds!


ABOUT THE PROGRAM
The SPOCK program is designed to attract early in career individuals with differing education, thinking, and cultural backgrounds in order to increase diversity among Roche’s future leaders.
"The SPOCKs choose a senior sponsor who shares their knowledge, perspective and experience whilst advocating and ensuring SPOCK visibility with decision makers.  The enterprise nurtures this talent through stretch assignments and participation in mission critical initiatives."

Linda Grosjean - Head, Portfolio & Program Management, pRED

Discover your own path.


You will spend the first year in the Portfolio & Program Management (PPM) team, part of the Strategy Portfolio & Clinical Operations function (SP&CO) which optimizes the pRED portfolio value by providing objective insights and guiding quality decision making to maximize R&D productivity.
​​​​​​​
The PPM team provides a great overview of the key work and projects across all of pRED, so that you can find an assignment you are passionate about - whether in PPM, or beyond. Current SPOCK members have worked in diverse teams on strategic reviews of disease areas, on tools to better predict drug candidate success and on licensing opportunities for new digital therapeutics, to name a few.

You will work on analyses of the pRED portfolio, business options and navigate through a complex data ecosystem. You will interact with key functions and disease therapeutic area (DTA) teams, providing a portfolio perspective that drives quality decision making and supports strategic objectives. Additionally, through your senior pRED leader mentor, you will have exposure to the Pharma Leadership Team of pRED (pLT).


Broad exposure to pRED during year 1 in PPM; find your fit in pRED in year 2 
img1

Year One
 
During the first year you will be working closely with both cross-functional and PPM teams where you will have the opportunity to learn more about the pRED organisation and lead your own assignments. You will also be afforded the time and support to find your assignment for the second year which can be in any other part of the pRED organisation i.e. in a DTA (I2O, NRD, Oncology) or in one of the global functions; Pharmaceutical Sciences, Therapeutic Modalities or pRED Finance & Operations. 

You will also be supported by your dedicated SPOCK program lead, PPM Head and have full access to key roles within PPM including the Data & Analytics Strategy lead and Capabilities & Development lead.
 

First year key responsibilities include
Hands-on involvement in the full data analysis process (from sourcing, cleaning and preparation, to analysis, model validation, insights and visualization). This includes communicating partial and final recommendations throughout projects.

Perform business analysis in support of strategic cross-portfolio projects and ensure alignment of cross-functional assumptions for a consolidated portfolio view, including the annual prioritization and business planning process.

Assist in acquiring, managing, and developing new data assets to support portfolio decision-making, and develop new and innovative analyses through the integration of various data sources.
You will need strong strategic, collaboration and communication skills, as well as an entrepreneurial mind-set.
img1

Year Two
You will have the opportunity to make your mark on the part of the pRED organisation you have chosen through high visibility projects and senior level challenges. We expect pRED  to benefit from your innovative mindset and your leadership development to have an impact through your second year stretch assignments.

Examples could include:
  • Product owner: optimisation of lab services pRED
  • Insights lead: new Data & Analytics organisation

Who you are?
img1
You have three years experience in the medical / pharmaceutical or scientific industries, are a life sciences or data sciences graduate with an advanced degree (MBA and/or PhD) desirable but not essential. You show a well-developed strategic and analytical mindset with a demonstrable ability to integrate and synthesize findings from multiple sources to enable informed strategic decision-making. An experience of influencing in a matrix organisation is a real asset for this role.
img1
Excellent oral communication / presentation skills are needed. You can explain your ideas, are persuasive & can demonstrate new approaches to problems.
You have a “can do” customer service spirit, collaborative attitude & flexibility to compromise, you are proactive & solutions-oriented having the ability to see the bigger picture.
You also have the ability to develop special skills, are open to new ideas, demonstrate curiosity, & have a thoughtful understanding of how previous experiences have shaped your attitudes, beliefs & behaviour.

Are you ready to apply?



We are looking for a person who thinks beyond the job offered - someone who knows that this position can be a rare springboard to many other opportunities at Roche.

Roche embraces diversity and equal opportunity in a serious way. We are committed to building teams that represent a range of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.

If you have questions then please check our FAQs and videos on careers.roche.ch/faq.
​​​​​​​
Roche is an equal opportunity employer. 

About Roche

Doing now what patients need next
We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future.

We are passionate about transforming patients’ lives.

We are courageous in both decision and action. And we believe that good business means a better world. That is why we come to work each day.

We commit ourselves to scientific rigor, unassailable ethics, and access to medical innovations for all.

We do this today to build a better tomorrow.

We are proud of who we are, what we do, and how we do it.

We are many, working as one across functions, across companies, and across the world.

We are Roche.

Innovation drives everything we do to improve people’s lives.
Our contribution to fighting the global pandemic:

  • Our colleagues in Pharma and Diagnostics are working day and night to meet the global demand of test materials - "Everyday heroes"
    ​​​​​​​
  • The first company to provide a high-throughput test, and a highly reliable antibody test at large scale

  • Roche Diagnostics launched a SARS-CoV-2 Rapid Antigen Test that provides results in 15min in Sep 2020

  • #strongertogether - Collaboration with Regeneron to significantly increase production of an antibody cocktail which showed in Phase III trial results to reduce the risk of symptomatic Covid-19 infections with Delta by 81%  (media release) 

  • FDA and EMA have authorized Roche Actemra (tocilizumab) for the treatment of severe Covid-19 infections

Frequently Asked Questions